QUEST DIAGNOSTICS INC

DGX

$21.59B

Large Cap

NASDAQServices-Medical LaboratoriesHealth care🇺🇸North AmericaSECAUCUS65.0K employees

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Website

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Oct 20, 2026

Market Overview

Stock performance and key metrics

DGX News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How DGX's past catalysts played out

earningsFeb 2026+7%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is QUEST DIAGNOSTICS INC's next FDA catalyst?→

QUEST DIAGNOSTICS INC's (DGX) next tracked catalyst is a Earnings expected October 20, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track DGX biotech catalysts?→

Add DGX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow QUEST DIAGNOSTICS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply